Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 5Unknown 2Recruiting 2Terminated 1Active not recruiting 1

Sponsor Class

OTHER 10INDUSTRY 3NIH 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Sarcoma 2CNS 1

Conditions

Neoplasms 30Prostatic Neoplasms 22Neoplasm Metastasis 20Breast Neoplasms 17Lung Neoplasms 16Colorectal Neoplasms 15Leukemia, Myeloid, Acute 14Pancreatic Neoplasms 13Ovarian Neoplasms 12Urinary Bladder Neoplasms 11Lymphoma 11Hematologic Neoplasms 11Carcinoma, Non-Small-Cell Lung 10Stomach Neoplasms 9Myelodysplastic Syndromes 9Squamous Cell Carcinoma of Head and Neck 8Sarcoma, Kaposi 8Pheochromocytoma 8Multiple Myeloma 8Melanoma 8Lymphoma, Non-Hodgkin 8Leukemia, Lymphocytic, Chronic, B-Cell 8Endometrial Neoplasms 8Carcinoma, Renal Cell 8Burkitt Lymphoma 8Neuroendocrine Tumors 7Mouth Neoplasms 7Kidney Neoplasms 7Glioma 7Thyroid Neoplasms 6

Interventions

enasidenib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × NIH × Chondrosarcoma × Clear all
NCT06176989 2026-06-03

Enasidenib in IDH2-Mutated Malignant Sinonasal and Skull Base Tumors

National Institutes of Health Clinical Center (CC)

Phase 2 Recruiting
40 enrolled
CNSSarcoma

Sinonasal undifferentiated carcinoma, Chondrosarcoma, Esthesioneuroblastoma, Olfactory

NCT06749366 2026-05-12

Uncovering Genes Behind Cartilage Tumors and Vascular Anomalies Using Genomic Sequencing

National Institutes of Health Clinical Center (CC)

Recruiting
100 enrolled
Sarcoma

Chondroma, Chondrosarcoma, Enchondromatosis, Hemangioma, Mucopolysaccharidosis IV

Data powered by HemOnc (CC BY 4.0) Colophon âš¡